134 related articles for article (PubMed ID: 25117211)
1. Neuroprotective effects of the anti-cancer drug sunitinib in models of HIV neurotoxicity suggests potential for the treatment of neurodegenerative disorders.
Wrasidlo W; Crews LA; Tsigelny IF; Stocking E; Kouznetsova VL; Price D; Paulino A; Gonzales T; Overk CR; Patrick C; Rockenstein E; Masliah E
Br J Pharmacol; 2014 Dec; 171(24):5757-73. PubMed ID: 25117211
[TBL] [Abstract][Full Text] [Related]
2. The anticancer drug sunitinib promotes autophagyand protects from neurotoxicity in an HIV-1 Tat model of neurodegeneration.
Fields JA; Metcalf J; Overk C; Adame A; Spencer B; Wrasidlo W; Florio J; Rockenstein E; He JJ; Masliah E
J Neurovirol; 2017 Apr; 23(2):290-303. PubMed ID: 28105557
[TBL] [Abstract][Full Text] [Related]
3. Increased CDK5 expression in HIV encephalitis contributes to neurodegeneration via tau phosphorylation and is reversed with Roscovitine.
Patrick C; Crews L; Desplats P; Dumaop W; Rockenstein E; Achim CL; Everall IP; Masliah E
Am J Pathol; 2011 Apr; 178(4):1646-61. PubMed ID: 21435449
[TBL] [Abstract][Full Text] [Related]
4. The induction of human myeloid derived suppressor cells through hepatic stellate cells is dose-dependently inhibited by the tyrosine kinase inhibitors nilotinib, dasatinib and sorafenib, but not sunitinib.
Heine A; Schilling J; Grünwald B; Krüger A; Gevensleben H; Held SA; Garbi N; Kurts C; Brossart P; Knolle P; Diehl L; Höchst B
Cancer Immunol Immunother; 2016 Mar; 65(3):273-82. PubMed ID: 26786874
[TBL] [Abstract][Full Text] [Related]
5. Impaired neurogenesis and neurite outgrowth in an HIV-gp120 transgenic model is reversed by exercise via BDNF production and Cdk5 regulation.
Lee MH; Amin ND; Venkatesan A; Wang T; Tyagi R; Pant HC; Nath A
J Neurovirol; 2013 Oct; 19(5):418-31. PubMed ID: 23982957
[TBL] [Abstract][Full Text] [Related]
6. Ethaverine and Papaverine Target Cyclin-Dependent Kinase 5 and Inhibit Lung Cancer Cell Proliferation and Migration.
Laure A; Royet C; Bihel F; Baratte B; Bach S; Peyressatre M; Morris MC
ACS Pharmacol Transl Sci; 2024 May; 7(5):1377-1385. PubMed ID: 38751642
[TBL] [Abstract][Full Text] [Related]
7. Exercise and the brain: a slap on the HAND.
Mattson MP
J Neurovirol; 2013 Oct; 19(5):407-9. PubMed ID: 24072548
[No Abstract] [Full Text] [Related]
8. Correction to: The anti-cancer drug Sunitinib promotes autophagy and protects from neurotoxicity in an HIV-1 Tat model of neurodegeneration. Journal of NeuroVirology 2017.
Masliah E
J Neurovirol; 2023 Oct; 29(5):644. PubMed ID: 37812315
[No Abstract] [Full Text] [Related]
9. Molecular determinants of α-synuclein mutants' oligomerization and membrane interactions.
Tsigelny IF; Sharikov Y; Kouznetsova VL; Greenberg JP; Wrasidlo W; Overk C; Gonzalez T; Trejo M; Spencer B; Kosberg K; Masliah E
ACS Chem Neurosci; 2015 Mar; 6(3):403-16. PubMed ID: 25561023
[TBL] [Abstract][Full Text] [Related]
10. The association between infectious burden and Parkinson's disease: A case-control study.
Bu XL; Wang X; Xiang Y; Shen LL; Wang QH; Liu YH; Jiao SS; Wang YR; Cao HY; Yi X; Liu CH; Deng B; Yao XQ; Xu ZQ; Zhou HD; Wang YJ
Parkinsonism Relat Disord; 2015 Aug; 21(8):877-81. PubMed ID: 26037459
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders.
Fields JA; Dumaop W; Crews L; Adame A; Spencer B; Metcalf J; He J; Rockenstein E; Masliah E
Curr HIV Res; 2015; 13(1):43-54. PubMed ID: 25760044
[TBL] [Abstract][Full Text] [Related]
12. Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer's disease patients.
Bayraktar A; Li X; Kim W; Zhang C; Turkez H; Shoaie S; Mardinoglu A
J Transl Med; 2023 May; 21(1):332. PubMed ID: 37210557
[TBL] [Abstract][Full Text] [Related]
13. FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders.
Lui A; Vanleuven J; Perekopskiy D; Liu D; Xu D; Alzayat O; Elgokhy T; Do T; Gann M; Martin R; Liu DZ
Pharmaceuticals (Basel); 2022 Dec; 15(12):. PubMed ID: 36558997
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective Effects of the Anti-cancer Drug Lapatinib Against Epileptic Seizures via Suppressing Glutathione Peroxidase 4-Dependent Ferroptosis.
Jia JN; Yin XX; Li Q; Guan QW; Yang N; Chen KN; Zhou HH; Mao XY
Front Pharmacol; 2020; 11():601572. PubMed ID: 33362556
[TBL] [Abstract][Full Text] [Related]
15. Regorafenib Regulates AD Pathology, Neuroinflammation, and Dendritic Spinogenesis in Cells and a Mouse Model of AD.
Han KM; Kang RJ; Jeon H; Lee HJ; Lee JS; Park H; Gak Jeon S; Suk K; Seo J; Hoe HS
Cells; 2020 Jul; 9(7):. PubMed ID: 32660121
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological enrichment of polygenic risk for precision medicine in complex disorders.
Reay WR; Atkins JR; Carr VJ; Green MJ; Cairns MJ
Sci Rep; 2020 Jan; 10(1):879. PubMed ID: 31964963
[TBL] [Abstract][Full Text] [Related]
17. Transgenic mice expressing HIV-1 envelope protein gp120 in the brain as an animal model in neuroAIDS research.
Thaney VE; Sanchez AB; Fields JA; Minassian A; Young JW; Maung R; Kaul M
J Neurovirol; 2018 Apr; 24(2):156-167. PubMed ID: 29075998
[TBL] [Abstract][Full Text] [Related]
18. Cross-sectional and longitudinal small animal PET shows pre and post-synaptic striatal dopaminergic deficits in an animal model of HIV.
Sinharay S; Lee D; Shah S; Muthusamy S; Papadakis GZ; Zhang X; Maric D; Reid WC; Hammoud DA
Nucl Med Biol; 2017 Dec; 55():27-33. PubMed ID: 29031113
[TBL] [Abstract][Full Text] [Related]
19. An Aberrant Phosphorylation of Amyloid Precursor Protein Tyrosine Regulates Its Trafficking and the Binding to the Clathrin Endocytic Complex in Neural Stem Cells of Alzheimer's Disease Patients.
Poulsen ET; Iannuzzi F; Rasmussen HF; Maier TJ; Enghild JJ; Jørgensen AL; Matrone C
Front Mol Neurosci; 2017; 10():59. PubMed ID: 28360834
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
